Relay Therapeutics announced that the company will host a New Program and Platform event on Thursday, June 6, 2024 from 8:00 to 10:00 a.m. ET. During the event, the company will disclose new programs from its existing pre-clinical pipeline and review how the Dynamo platform led to these novel discoveries.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RLAY:
- Relay Therapeutics upgraded to Overweight from Equal Weight at Barclays
- Relay Therapeutics price target lowered to $25 from $33 at Oppenheimer
- Relay Therapeutics reports Q1 EPS (62c), consensus (71c)
- Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
- Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024